{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:22:29Z","timestamp":1787055749520,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.canep.2022.102292","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T15:47:22Z","timestamp":1668786442000},"page":"102292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study"],"prefix":"10.1016","volume":"82","author":[{"given":"B.","family":"Delapierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dejardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2022.102292_bib1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2022.102292_bib2","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"Zenz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canep.2022.102292_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canep.2022.102292_bib4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2022.102292_bib5","first-page":"16","article-title":"Agriculture et h\u00e9mopathies malignes chez l\u2019adulte-Quel r\u00f4le des expositions professionnelles aux pesticides?","volume":"36","author":"Busson","year":"2020","journal-title":"M\u00e9d. Sci."},{"key":"10.1016\/j.canep.2022.102292_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109332","article-title":"Non-hodgkin lymphoma risk and insecticide, fungicide and fumigant use in the agricultural health study","volume":"9","author":"Alavanja","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2022.102292_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ypmed.2013.12.007","article-title":"European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France","volume":"63","author":"Ou\u00e9draogo","year":"2014","journal-title":"Prev. Med."},{"key":"10.1016\/j.canep.2022.102292_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/CEJ.0000000000000326","article-title":"Socioeconomic status and site-specific cancer incidence, a Bayesian approach in a French cancer registries network study","volume":"27","author":"Bryere","year":"2018","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.canep.2022.102292_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ijc.31951","article-title":"Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: an analysis of the French network of cancer registries (FRANCIM) data","volume":"144","author":"Tron","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib10","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2008.06.023","article-title":"Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994-2003","volume":"44","author":"Dalton","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6605752","article-title":"Socioeconomic inequalities in cancer survival in England after the NHS cancer plan","volume":"103","author":"Rachet","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib12","doi-asserted-by":"crossref","first-page":"k764","DOI":"10.1136\/bmj.k764","article-title":"Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study","volume":"360","author":"Exarchakou","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2022.102292_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1055-9965.EPI-08-0685","article-title":"Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis","volume":"18","author":"Jeffreys","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2022.102292_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bjc.6605861","article-title":"Education, survival and avoidable deaths in cancer patients in Finland","volume":"103","author":"Pokhrel","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bjc.6603980","article-title":"Socioeconomic inequalities in cancer survival in Scotland 1986-2000","volume":"97","author":"Shack","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3324\/haematol.2016.152918","article-title":"Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role","volume":"102","author":"Le Guyader-Peyrou","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.canep.2022.102292_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jech-2015-205729","article-title":"Development of a cross-cultural deprivation index in five European countries","volume":"70","author":"Guillaume","year":"2016","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.canep.2022.102292_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1055-9965.EPI-11-0038","article-title":"Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation","volume":"20","author":"Clarke","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2022.102292_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.annepidem.2005.09.002","article-title":"Socioeconomic\/occupational risk factors for lymphoproliferative diseases in Sweden","volume":"16","author":"Ji","year":"2006","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.canep.2022.102292_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bulcan.2018.08.014","article-title":"\u00c9valuation de la disparit\u00e9 de prise en charge des patients avec une leuc\u00e9mie lympho\u00efde chronique en France","volume":"105","author":"Rateau","year":"2018","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib21","unstructured":"L. Tron, L. Launay, J. Bryere, A. Monnereau, O. Dejardin, G. Launoy, Influence de l\u2019environnement social sur la survie des patients atteints d\u2019un cancer en France. Etude du r\u00e9seau FRANCIM. Bull Epid\u00e9miol Hebd \u3008http:\/\/beh.santepubliquefrance.fr\/beh\/2021\/5\/2021_5_2.html\u3009, 2021 (Accessed 7 April 2021)."},{"key":"10.1016\/j.canep.2022.102292_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"key":"10.1016\/j.canep.2022.102292_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/sim.4780090506","article-title":"Relative survival and the estimation of net survival: elements for further discussion","volume":"9","author":"Est\u00e8ve","year":"1990","journal-title":"Stat. Med."},{"key":"10.1016\/j.canep.2022.102292_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2022.102292_bib25","unstructured":"T. Lang, C. Cases, P. Chauvin, E. Jougla, F. Jusot, A. Laporte, P. Lombrail, G. Menvielle, Indicateurs de Suivi de L'\u00e9volution des In\u00e9galit\u00e9s Sociales de Sant\u00e9 dans les Syst\u00e8mes D'information en sant\u00e9, Haut Conseil de la Sant\u00e9 Publique, Francaise, 2013."},{"key":"10.1016\/j.canep.2022.102292_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/sim.1597","article-title":"Regression models for relative survival","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.canep.2022.102292_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/sim.3762","article-title":"Estimating the crude probability of death due to cancer and other causes using relative survival models","volume":"29","author":"Lambert","year":"2010","journal-title":"Stat. Med."},{"key":"10.1016\/j.canep.2022.102292_bib28","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2022.102292_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.canep.2022.102292_bib30","series-title":"Multiple Imputation For Nonresponse In Surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.canep.2022.102292_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0609.1994.tb00192.x","article-title":"Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia","volume":"53","author":"Mellemgaard","year":"1994","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.canep.2022.102292_bib32","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1038\/s41375-020-0987-6","article-title":"Second cancer incidence in CLL patients receiving BTK inhibitors","volume":"34","author":"Bond","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.canep.2022.102292_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"27","author":"Tsimberidou","year":"2009","journal-title":"J. Clin. Oncol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:31:24Z","timestamp":1761802284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782122001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"alternative-id":["S1877782122001977"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2022.102292","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2022.102292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102292"}}